Navigation Links
New Microbial Genome-to-Array Service
Date:12/10/2007

ing innovative and creative technologies for genomic research is the corporate mission of the febit group, a German-American biotech company. Geniom is a technological and service platform successfully used in basic and applied research of renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes providing superior time and cost efficiency combined with an unsurpassed spectrum of applications. With the Geniom Technology febit now enters the high-potential market of synthetic biology with a novel method for production of synthetic genes. Using both, highly integrated automation and extensive customizability, febit meets essential needs of current biomedical research.
http://www.febit.com

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manage +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
SOURCE febit
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
2. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
3. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
4. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
5. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
6. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
7. Pharsight Expands Strategic Consulting Services Team
8. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
9. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wswire/ -- Myriant Technologies LLC ("Myriant"), a...r of renewable bio-chemicals, Uhde Corporation of...e GmbH, one of the world,s leading engineering con...or the engineering, procurement & construction...based on renewable feedstocks. The execution of t...
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...Sales Grow to $10.5 Million in 2007; MOXATAG, Comp...r-end; Process to Explore Strategic ... March 4 MiddleBrook,Pharmaceuticals, Inc. (Nasda...veloping and commercializing novel anti-infective ...l results for the quarter and fiscal year,ended De...
...h 4 SGX Pharmaceuticals,(Nasdaq: SGXP ) will ann...,full year 2007 on Wednesday, March 12, 2008. The ... call and webcast at 8:00 a.m. Pacific Time.,Mike ...odd Myers, Chief,Financial Officer, will host the ...usiness highlights., Interested participants and ...
... teams led by Dr. Michael Verkhovsky and Prof. Mrt...e University of Helsinki have for the first time s...x I in real time. In the future, this work might, ...of the maternally inherited so-called mitochondria... , This achievement required developing and build...
Other Biology Technology:MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 2MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 3MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 4MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 5MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 6MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 7MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 8MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 9MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 10MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 11MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 12MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 13MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 14MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results 15SGX Pharmaceuticals Schedules Teleconference and Webcast for Fourth Quarter and Full Year 2007 Results 2Biological electron transfer captured in real time 2
(Date:11/4/2009)... Singapore laboratory that deciphered the DNA code...nd elephant shark, has joined The Genome 10K Proje... repository of DNA sequences on 10,000 species of ...ale that currently can not be achieved. , Partic...paper published in the Nov. 5, 2009 issue of the ...
(Date:11/4/2009)... MADISON, N.J., Oct. 20 ...world,s leading provider of diagnostic testing, in...rd quarter ended September 30, 2009, income from c...2 per diluted share, from $160 million, or $0.81 p...n 2008, third quarter results were reduced by a $0...
(Date:11/4/2009)... RIDGE, N.Y., Oct. 21 What,s the c...venting accidental death resulting from prescripti... with good intentions, however, may be unaware tha...ing their teens from the ticking timebomb of presc...eader in premium-quality medical supplies, has for...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 1Suicide Genes Help Slow Ovarian Tumor Growth in Mice 53210 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 1Palomar Medical Reports Financial Results for Second Quarter 2009 53208 2Palomar Medical Reports Financial Results for Second Quarter 2009 53208 3Palomar Medical Reports Financial Results for Second Quarter 2009 53208 4Palomar Medical Reports Financial Results for Second Quarter 2009 53208 5Palomar Medical Reports Financial Results for Second Quarter 2009 53208 6Palomar Medical Reports Financial Results for Second Quarter 2009 53208 7Palomar Medical Reports Financial Results for Second Quarter 2009 53208 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 1CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 2CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 3CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 4CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 5CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 6CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 7CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 8CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 9CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 10CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 11CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 12CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 13CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 14CryoLife Reports Record Quarterly Revenues of 2428 2 Million 53206 15
...rchers have decoded the genetic makeup of the para...ommon sexually transmitted infections (STIs), reve...ecome increasingly drug resistant and suggesting p...nd a potential vaccine strategy. The genome sequen...Allergy and Infectious Diseases (NIAID), part of t...
... there is no cure for lingering viral infections s... University suggests it may be possible to deactiv...genetic switch. , Princeton scientists Leor Weinb...nate the processes by which human immunodeficiency...mant phases in their hosts. The researchers have d...
...ional workplace ban on smoking in Ireland resulted...bs, an 80 percent decrease in airborne carcinogens...respiratory health of bar workers, according to a ...n the second issue for April 2007 of the American ... published by the American Thoracic Society. , ...
Other Biology News:Scientists sequence genome of parasite responsible for common sexually transmitted infection 2Scientists sequence genome of parasite responsible for common sexually transmitted infection 3Scientists find potential 'off-switch' for HIV virus 2Scientists find potential 'off-switch' for HIV virus 3Scientists find potential 'off-switch' for HIV virus 4Smoking ban dramatically reduces air pollution in Irish pubs 2Smoking ban dramatically reduces air pollution in Irish pubs 3
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Goat Anti-Syne-1 (N-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: